Needle-free Injection Systems Market by Product - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ID: 4403186
  • Report
  • Region: Global
  • 150 pages
  • Allied Analytics LLP
1 of 3
Needle-free injectors are used to administer drugs and vaccines into patients without pricking the skin as done in case of conventional needles. The global needle-free injection system market was valued at $8,166 million in 2016, and is estimated to reach $23,116 million by 2023, growing at a CAGR of 16.0% from 2017 to 2023. The market is expected to witness significant growth during the forecast period owing to improved immunization coverage, increase in demand for self-injection devices, prevalence of chronic diseases, incidence of communicable diseases due to needle stick injuries, and reduction in healthcare costs. However, dearth of trained personnel and limitation in usage for intravenous administration restrict the market growth.

The global needle-free injection system market is segmented on the basis of product, source of power, type, usability, site of delivery, application, end user, and region. Based on product, it is bifurcated into fillable and prefilled needle-free injection systems. Based on source of power, it is divided into spring-based and gas-propelled/air forced injector systems. According to type, the market is categorized into liquid-based, projectile/depot-based, and powder-based. On the basis of usability, it is divided into disposable and reusable needle-free injectors.

On the basis of site of delivery, the market is segmented into subcutaneous, intramuscular, and intradermal injectors. Based on application, it is divided into vaccine delivery, insulin delivery, pain management, and others. According to the end user, it is classified into hospitals & clinics, home care settings, research laboratories, and others. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The global needle-free injection system market is highly competitive and is lucrative in nature. The key market players have adopted various developmental strategies such as product launch & approval, strategic acquisitions, and mergers to strengthen their market position.

KEY BENEFITS FOR STAKEHOLDERS

The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors.
It offers an extensive analysis of the current and emerging market trends and dynamics through 2016–2023 to identify the upcoming market opportunities.
Recent industry trends and developments and the future opportunities are also covered.
Extensive knowledge about the key market players and their strategies is provided.
Comprehensive analysis of factors that drive and restrain the growth of the market is provided.

KEY MARKET SEGMENTS

By Product

Fillable
Prefilled

By Source of Power

Spring-based Injectors Systems
Gas Propelled/Air Forced Injectors Systems

By Type

Liquid-based
Projectile/Depot-based
Powder-based

By Usability

Disposable
Reusable

By Site of Delivery

Subcutaneous Injectors
Intramuscular Injectors
Intradermal Injectors

By Application

Vaccine Delivery
Insulin Delivery
Pain Management
Others

By End User

Hospitals & Clinics
Home Care Settings
Research Laboratories
Others

By Region

North America
U.S.
Canada
Mexico
Europe
France
Germany
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa

Key market players

The key players operating in this market include the following:
Antares Pharma, Inc.
Endo International plc
PenJet Corporation
Crossject Needle-Free Injection Systems
PharmaJet
Medical International Technology, Inc.
INJEX Pharma AG
National Medical Products Inc.
Valeritas, Inc.
European Pharma Group
READ MORE
Note: Product cover images may vary from those shown
2 of 3
CHAPTER 1 INTRODUCTION

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top wining strategies

3.2.1.1. Competitive intelligence of companies and their strategies

3.2.2. Top investment pockets

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Improved Immunization Coverage
3.3.1.2. Eliminate Risks of Needles
3.3.1.3. Reduce Health Care Costs
3.3.1.4. Increasing patient power

3.3.2. Restrains

3.3.2.1. Dearth of trained personnel
3.3.2.2. Limitation in intravenous administration

3.3.3. Opportunities

3.3.3.1. Wider range of applications
3.3.3.2. Technological advancements

3.3.4. Impact analysis

3.4. MARKET SHARE ANALYSIS, 2016
3.5. GOVERNMENT REGULATIONS
3.6. CLINICAL TRIALS

CHAPTER 4 NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. FILLABLE NEEDLE-FREE INJECTORS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. PREFILLED NEEDLE-FREE INJECTORS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

CHAPTER 5 NEEDLE-FREE INJECTION SYSTEM MARKET, BY SOURCE OF POWER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. SPRING-BASED NEEDLE-FREE INJECTORS

5.2.1. Market size and forecast

5.3. GAS PROPELLED/ AIR FORCED INJECTOR SYSTEMS

5.3.1. Market size and forecast

CHAPTER 6 NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. LIQUID-BASED NEEDLE FREE INJECTORS

6.2.1. Market size and Forecast

6.3. PROJECTILE/DEPOT-BASED NEEDLE-FREE INJECTORS

6.3.1. Market size and forecast

6.4. POWDER-BASED NEEDLE FREE INJECTORS

6.4.1. Market size and forecast

CHAPTER 7 NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. SUBCUTANEOUS INJECTORS

7.2.1. Market size and forecast

7.3. INTRAMUSCULAR INJECTORS

7.3.1. Market size and forecast

7.4. INTRADERMAL INJECTORS

7.4.1. Market size and forecast

CHAPTER 8 NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. DISPOSABLE NEEDLE-FREE INJECTORS

8.2.1. Market size and forecast

8.3. REUSABLE NEEDLE-FREE INJECTORS

8.3.1. Market size and forecast

CHAPTER 9 NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION

9.1. OVERVIEW

9.1.1. Market size and forecast

9.2. VACCINE DELIVERY

9.2.1. Market size and forecast

9.3. INSULIN DELIVERY

9.3.1. Market size and forecast

9.4. PAIN MANAGEMENT

9.4.1. Main size and forecast

9.5. OTHER APPLICATIONS

9.5.1. Market size and forecast

CHAPTER 10 NEEDLE-FREE INJECTION SYSTEM MARKET, BY END-USER

10.1. OVERVIEW

10.1.1. Market size and forecast

10.2. HOSPITALS AND CLINICS

10.2.1. Market size and forecast

10.3. HOME CARE SETTINGS

10.3.1. Market size and forecast

10.4. RESEARCH LABORATORIES

10.4.1. Market size and forecast

10.5. OTHER END USERS

10.5.1. Market size and forecast

CHAPTER 11 NEEDLE-FREE INJECTION SYSTEM MARKET, BY REGION

11.1. OVERVIEW

11.1.1. Market size and forecast

11.2. NORTH AMERICA

11.2.1. Key market trends
11.2.2. Growth factors and opportunities
11.2.3. Market size and forecast

11.2.3.1. U.S. market size and forecast
11.2.3.2. Canada market size and forecast
11.2.3.3. Mexico market size and forecast

11.3. EUROPE

11.3.1. Key market trends
11.3.2. Growth factors and opportunities
11.3.3. Market size and forecast

11.3.3.1. Germany market size and forecast
11.3.3.2. France market size and forecast
11.3.3.3. UK market size and forecast
11.3.3.4. Italy market size and forecast
11.3.3.5. Spain market size and forecast
11.3.3.6. Rest of Europe market size and forecast

11.4. ASIA-PACIFIC

11.4.1. Key market trends
11.4.2. Growth factors and opportunities
11.4.3. Market size and forecast

11.4.3.1. Japan market size and forecast
11.4.3.2. China market size and forecast
11.4.3.3. India market size and forecast
11.4.3.4. Australia market size and forecast
11.4.3.5. Rest of Asia-Pacific market size and forecast

11.5. LAMEA

11.5.1. Key market trends
11.5.2. Growth factors and opportunities
11.5.3. Market size and forecast

11.5.3.1. Brazil market size and forecast
11.5.3.2. South Africa market size and forecast
11.5.3.3. Saudi Arabia market size and forecast
11.5.3.4. Rest of LAMEA market size and forecast

CHAPTER 12 COMPANY PROFILES

12.1. ANTARES PHARMA, INC.

12.1.1. Company overview
12.1.2. Operating business segments
12.1.3. Business performance
12.1.4. Key strategic moves and developments

12.2. MEDICAL INTERNATIONAL TECHNOLOGY, INC.

12.2.1. Company overview
12.2.2. Operating business segments
12.2.3. Business performance
12.2.4. Key strategic moves and developments

12.3. INJEX PHARMA AG

12.3.1. Company overview
12.3.2. Operating business segments
12.3.3. Business performance
12.3.4. Key strategic moves and developments

12.4. NATIONAL MEDICAL PRODUCTS INC.

12.4.1. Company overview
12.4.2. Operating business segments
12.4.3. Business performance
12.4.4. Key strategic moves and developments

12.5. EUROPEAN PHARMA GROUP

12.5.1. Company overview
12.5.2. Operating business segments
12.5.3. Business performance
12.5.4. Key strategic moves and developments

12.6. VALERITAS, INC.

12.6.1. Company overview
12.6.2. Operating business segments
12.6.3. Business performance
12.6.4. Key strategic moves and developments

12.7. PHARMAJET

12.7.1. Company overview
12.7.2. Operating business segments
12.7.3. Business performance
12.7.4. Key strategic moves and developments

12.8. PENJET CORPORATION

12.8.1. Company overview
12.8.2. Operating business segments
12.8.3. Business performance
12.8.4. Key strategic moves and developments

12.9. CROSSJECT NEEDLE-FREE INJECTION SYSTEMS

12.9.1. Company overview
12.9.2. Operating business segments
12.9.3. Business performance
12.9.4. Key strategic moves and developments
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll